ARPA-H Launches $62.7M Program to Build FDA-Authorized Agentic AI for Heart Failure Care
HealthcareLdr · x · 2026-09-13
- ARPA-H launched ADVOCATE, a $62.7M program to build patient-facing agentic clinical AI for cardiovascular care, focused on heart failure.
- The goal is an autonomous "digital member of the care team" that continuously monitors heart failure patients, provides some care between visits, and escalates issues to clinicians. Selected teams will build patient-facing AI, a supervisory agentic AI, and a scalable deployment plan.
- A key element is close collaboration with the FDA to establish a regulatory framework for a new class of autonomous clinical AI, with partners including Kaiser Permanente.
More from Safety
- OpenAI reportedly to train on users' Daybreak sessions with no opt-out — dyn___ · 2026-10-31
- Forethought: US has 9x China's AI compute, can afford to pace the frontier — willmacaskill · 2026-10-31
- unpromptedconf takeaways: security programs face forced change as reachable vulnerabilities can't be risk-accepted — scottleibrand · 2026-10-31
- Reachable vulnerabilities can't be risk-accepted away, unpromptedconf speaker argues — scottleibrand · 2026-10-31
- AI safety researchers argue labs' silence on x-risk is a large-scale ethical mistake — DavidSKrueger · 2026-10-31
- AI agent Muse reportedly created Windows user accounts without consent — tHE_uKER · 2026-10-31